相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dysfunction of the locus coeruleus-norepinephrine system and related circuitry in Parkinson's disease-related dementia
Kelly Del Tredici et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
Genomic Analysis of Reactive Astrogliosis
Jennifer L. Zamanian et al.
JOURNAL OF NEUROSCIENCE (2012)
Lipopolysaccharide-induced nigral inflammation leads to increased IL-1β tissue content and expression of astrocytic glial cell line-derived neurotrophic factor
Mahmoud M. Iravani et al.
NEUROSCIENCE LETTERS (2012)
Norepinephrine enhances the LPS-induced expression of COX-2 and secretion of PGE2 in primary rat microglia
Johannes C. M. Schlachetzki et al.
JOURNAL OF NEUROINFLAMMATION (2010)
An immunohistochemical and stereological analysis of PSI-induced nigral neuronal degeneration in the rat
Salma Bukhatwa et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Continuous subcutaneous infusion of pramipexole protects against lipopolysaccharide-induced dopaminergic cell death without affecting the inflammatory response
Mahmoud M. Iravani et al.
EXPERIMENTAL NEUROLOGY (2008)
PPARs in the brain
Michael T. Heneka et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2007)
Repeated administration of the noradrenergic neurotoxin N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) modulates neuroinflammation and amyloid plaque load in mice bearing amyloid precursor protein and presenilin-I mutant transgenes
Perdita L. Pugh et al.
JOURNAL OF NEUROINFLAMMATION (2007)
Different parkinsonism models produce a time-dependent induction of COX-2 in the substantia nigra of rats
Marcelo de Meira Santos Lima et al.
BRAIN RESEARCH (2006)
3-Nitrotyrosine-dependent dopaminergic neurotoxicity following direct nigral administration of a peroxynitrite but not a nitric oxide donor
MM Iravani et al.
BRAIN RESEARCH (2006)
The acute and the long-term effects of nigral lipopolysaccharide administration on dopaminergic dysfunction and glial cell activation
MM Iravani et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Reduced MPTP toxicity in noradrenaline transporter knockout mice
KS Rommelfanger et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Potentiation of parkinsonian symptoms by depletion of locus coeruleus noradrenaline in 6-hydroxydopamine-induced partial degeneration of substantia nigra in rats
J Srinivasan et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2003)
Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration
P Teismann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Noradrenergic depletion increases inflammatory responses in brain:: effects on IκB and HSP70 expression
MT Heneka et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Staging of brain pathology related to sporadic Parkinson's disease
H Braak et al.
NEUROBIOLOGY OF AGING (2003)
Up-regulation of inducible nitric oxide synthase in the substantia nigra by lipopolysaccharide causes microglial activation and neurodegeneration
T Arimoto et al.
NEUROBIOLOGY OF DISEASE (2003)
Noradrenergic regulation of inflammatory gene expression in brain
DL Feinstein et al.
NEUROCHEMISTRY INTERNATIONAL (2002)
Where does Parkinson disease pathology begin in the brain?
K Del Tredici et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2002)
Involvement of inducible nitric oxide synthase in inflammation-induced dopaminergic neurodegeneration
MM Iravani et al.
NEUROSCIENCE (2002)
Noradrenaline provides long-term protection to dopaminergic neurons by reducing oxidative stress
JD Troadec et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Catecholamines inhibit microglial nitric oxide production
JY Chang et al.
BRAIN RESEARCH BULLETIN (2000)
The single intranigral injection of LPS as a new model for studying the selective effects of inflammatory reactions on dopaminergic system
AJ Herrera et al.
NEUROBIOLOGY OF DISEASE (2000)
分享论文
